A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
About one-third of families with a child undergoing treatment for acute lymphoblastic leukemia experienced catastrophic income loss during therapy, with many developing new material hardships over the ...
The report charts major advances in precision oncology and immunotherapy but also reveals stagnant survival for several ...
Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL)—the most common ...
Investigators evaluated outcomes for patients with pediatric AML with and without etoposide during first-line induction treatment.
Advanced therapies have helped boost the 5-year survival rates for some cancers above 90%. But many other forms remain difficult to treat, and 'there aren't many good drugs.' ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...
Every parent knows that feeling. Your child seems a little off. Not quite themselves. Maybe they’re more tired than usual or have a bruise that appeared out of nowhere. Most of the time, it’s nothing ...
A new report highlights the stories of kids who have survived cancer and the importance of research funding.
Seeking to help researchers find a new treatment approach for children fighting cancer recurrence, cannabis industry pioneer Joe Caltabiano, co-founder of Cresco Labs (OTC: CRLBF) and founder of JSC ...
He says he wants every kid "to know they are never 'different' in a way that limits them." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback